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Background: Radiotherapy is among the most efﬁcient treatment methods of cancer. How-
ever, a radiotherapy base needs a substantial ﬁnancial investment, especially before the
beginning of its operation, and in some cases, in developing countries such a huge invest-
ment may cause some ﬁnancial disturbances for a hospital concerned.
Aim:To assess the inﬂuence of investmentsmodernizing the radiotherapy base in the period
between 2000 and 2007 on the ﬁnancial condition of the oncology hospital in the regionwith
population of about 3 million.
Material and methods: Financial reports and medical statistics for the period between 2000
and 2007 from the studied oncology hospital and a recognized stafﬁng model, as well as
data on epidemiological situation of the region have been used to calculate the economic
effects of ﬁnancial investment in the radiotherapy base.
Results: The growth of RT therapeutic potential has been driven by two cost-effective invest-
ment programmes. The total amount invested in both programmes was PLN 127,191,000.
The number of radiotherapy patients treated in the hospital increased from 2301 in 2000
to 4799 in 2007 with a the same number of ﬁve therapeutic machines, although all ﬁve
of them were replaced over that period. Investments modernizing the radiotherapy base
lead to a signiﬁcant increase in depreciation and operating costs, which adversely affectsﬁnancial results of the hospital.
Conclusion: Long term trends showed that investments had positive inﬂuence on hospital
performance shown both in increased income and larger number of patients treated.
© 2012 Published by Elsevier Urban & Partner Sp. z o.o. on behalf of Greater Poland
ever, the process of preclinical research of new radiotherapy. Backgroundhe health care sector can always consume more money
han is available. It is mostly due to the development in sci-
nce, clinical practices, and introduction of new technology.1
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Improvement in technologically sophisticated radiotherapy
allows to bring new treatment methods to patients. How-, 61 – 866 Poznan´, Poland. Tel.: +48 061 8850642.
equipment and than its implementation into clinical prac-
tice is expensive and requires a very long evaluation, which
increases economic cost for the health care system. On the
.o. on behalf of Greater Poland Cancer Centre.
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Table 1 – The number of radiotherapy treatments in relation to the number of therapeutic machines in the GPCC in
2000–2007.
Year Number of radiotherapy
patients
Total number of
therapeutic machines.
Number of purchased
therapeutic machines
2000 2.111 5 0
2001 2.557 5 0
2002 3.353 5 0
2003 4.381 5 1
2004 4.794 5 1
2005 5.462
2006 5.348
2007 5.701
other hand, clinical evaluation of sophisticated radiotherapy
equipment is problematic from the ethical point of view.2,3
One of the issues is that, in practice, it is difﬁcult to con-
struct a clinical trial in which patients will be assigned to
an old, i.e. probably less efﬁcient therapeutic machine rather
than to a new one. This is how new technologies, like three-
dimensional conformal radiotherapy (3DCRT) and intensity
modulated radiation therapy (IMRT), were introduced into
clinical practice worldwide.4 The cost-effectiveness of this
new sophisticated radiotherapy machines and tools for one
patient could be sometimes questioned, therefore, a careful
analysis is required of how it affects a hospital budget. This
issue is evenmore important when a hospital is amajor radio-
therapy provider in a region, thus being expected to provide
a larger number of sophisticated and expensive procedures
than smaller providers.
2. Aim
The aim of this study was to evaluate the inﬂuence of the
investments modernizing the radiotherapy base in the period
between 2000 and 2007 on the ﬁnancial condition of the oncol-
ogy hospital in the region with population of about 3 million.
3. Materials and methods
The description of radiotherapy service for the studied region
was based on information received from the GPCC records,
concerning the number of patients and type of radiother-
apy treatment applied in the years 2000–2007. The population
demand for radiotherapy treatment in the analyzed region
was evaluated based on data from the Greater Poland Can-
cer Registry, which included cancer incidence recorded from
2000 to 2007. Data concerning the amounts of money paid to
the hospital were taken from the hospital database and from
the National Health Fund (the institution which contracts and
reimburses medical procedures). The inﬂuence of the mod-
ernization of the radiotherapy base on the ﬁnancial condition
of the GPCC was assessed for the period of 2000–2007. These
data were retrieved from ﬁnancial reports – balance sheet,
proﬁt and loss statement and unit activity reports, taking into
consideration medical statistics.An inductive approachwas used for which status at certain
starting point was described and studied allowed for theoreti-
cal generalization.5 These theories are derived fromsociology6
and also widely used in the organization and management5 1
5 1
5 1
theory7. In addition, these allow to check whether speciﬁc
modernization processes in speciﬁc conditions could have led
to impairment of the ﬁnancial condition of a health care unit.
4. Results
The growth of RT therapeutic potential was driven by two
cost-effective investment programmes. The ﬁrst of them was
implemented in the period of 2000–2006 for a total amount
of PLN 70,518,000 and was funded in a large part by the
state budget. The other programme, carried out in 2004–2007,
involved the investment of PLN 56,673,000, including PLN
30,908,000 coming from the Greater Poland Cancer Centre’s
own resources and PLN 25,765,000 from EU funds. The total
amount invested in both programmes was PLN 127,191,000.
Focusing investment activity on radiotherapy was dictated
by both therapeutic needs and very high proﬁtability of
this particular type of medical service. The Greater Poland
Cancer Centre maintained its ﬁnancial liquidity throughout
the period of 2000–2007. In each of these years, the Centre
recorded positive balances, with the exception of 2007 when
depreciation of newly activated tangible assets soared rapidly
to almost PLN 16 million. But already in the following year of
2008, owing to a large extent to the increase in the material
base of radiotherapy and income from radiotherapy services
amounting to PLN30million, the accounts of thehospitalwere
closed with a positive balance.
The Greater Poland province is a region of 70,000km2
situated in the western part of Poland with administrative
capital in Poznan and inhabited by 3,200,000 people. Approx-
imately 12,800 new cases of cancer are expected per year,
which corresponds well with cancer registry data. More than
6400 patientsmay need radiotherapy treatment depending on
the case mix, and this number was quite stable throughout
the study period, considering size of the population studied.
A potential change during the study period could be caused
by the implementation of a screening program, but this effect
had direct impact neither on the procedure cost nor on the
reimbursement. In 2007, 5701 out of potential 6400 radiother-
apy patients were treated in the GPCC (Table 1). The total
number of patients recruited to radiotherapy inGPCCwas con-
stantly increasing from 2050 in 2000 to 4799 in 2007, and it
affected the equipment and personnel workload. The number
of patients treated on one accelerator increased from 410 in
2000 to 960 in 2007. The proportion of conformal radiotherapy
which applied more sophisticated techniques (3DCRT, IMRT)
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Table 2 – Proportion of income associated with the value of radical radiotherapy procedures in general value of
procedures during 2000–2007.
Year Value of reimbursement of
all radiotherapy procedures
in thousands of PLN
Value of reimbursement of
conformal (3DCRT, IMRT)
radiotherapy procedures in
thousands of PLN
Percentage of the value of
conformal radiotherapy in
the value of all
radiotherapy procedures
2000 40,416 7833 19.4%
2001 45,356 8024 17.7%
2002 53,851 8525 15.8%
2003 59,201 9042 15.3%
2004 64,661 10,296 15.9%
2005 80,674 16,905 21.0%
2006 91,249 20,990 23.0%
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Source: Own study based on GPCC’s reports.
n the reimbursed value of all radiotherapy procedures pro-
ided in the studied period grew from 19.4% in 2000 to 23.9%
n 2007 (Table 2).(Table 3).
The investigated period also saw a signiﬁcant share of
adiotherapy in generating institutional income, from 19.4%
n 2000 to 23.9% in 2007 (Table 2) achieved with an increase in
orkload of clinical staff in radiotherapy. The number of radi-
tion oncologists (residents excluded) increased by 33% from
000 to 2007 (Table 4). However, the value of reimbursement
btained from the refunding institution increased by 230% in
he same period, which shows the increase in work efﬁciency
f the radiotherapy staff.
The purchase of equipment and its use had a signiﬁcant
mpact on the economic status, especially in radiotherapy
here initial costs of therapeutic machines were high in
omparison to other medical disciplines. The changes in the
hare of accelerators in the total value of medical equipment
nd appliances in the hospital in 2000–2007 are presented in
able 5.
These data show a very strong increase in the value of
ccelerators, from 31.5% to 43.1%, that took place in the years
002–2005 (Table 5).
The year 2004 marked the beginning of a widening gap
etween the growth rate of investment in accelerators and
he growth rate of investment in other appliances andmedical
quipment, which is presented in Fig. 1.
Tables 4 and5 show the economicparameters for thehospi-
al. Table 6 shows the depreciation costs for thewhole hospital
Table 3 – Expenses on key objectives under the
Radiotherapy Development programme (in thousands of
PLN).
Key project objectives Investment
Radiotherapy Ward 28,268
CT 525
Radiotherapy Department 11,478
Accelerator 294
CT 1732
Accelerator 12,495
Mould Room 166
Treatment planning systems 1539
Beds 176
Total 56,67325,297 23.9%
in the years 2000–2007 and Table 5 ﬁnancial results in terms
of income and costs.
5. Discussion
In this study, authors investigated the potential inﬂuence
of investment in radiotherapy infrastructure on the hospital
budget in the region with population of 3.2 million, where
the studied hospital was a major radiotherapy provider. In
2000–2007, the investment activity was mainly connected
with the purchase and installation of sophisticated medical
equipment, especially for radiotherapy. It led to the hospital’s
ﬁnancial loss (negative balance sheet result) in 2007, which
occurred in the last year of the study period.
In the last three years of the investigated period, there was
a clear divergence between the increase in the value of accel-
erators and the increase in the value of all hospital medical
equipment, i.e. in 2005–2007 the value of all hospital medical
equipment grew faster than the value of accelerators (Fig. 1).
This process inﬂuenced the economic results but cannot be
explained based on the results revealed in the present study.
Among many investment undertakings carried out by the
Greater Poland Cancer Centre in the period of 1999–2007,
two major investment programmes were of particular impor-
tance: “Enlargement of the Greater Poland Cancer Centre” and
“Improvement of Standards of and Access to Specialist Cancer
Treatment (Radiotherapy) in the Wielkopolska Region”.
The ﬁrst of those programmes related to modernization of
the existing and construction of new hospital infrastructure,
including buildings and technical installations. The infras-
tructure was aimed to be used mostly for the purposes of
radiotherapy as well as other areas of cancer treatment. In
the years 2000–2003, the programme was – at the end of the
day – ﬁnanced by funds from the state budget allocated to the
hospital through government, regional or local administration
units. In 2004–2006, under new regulations, the hospital was
obliged to contribute in the ﬁnancing of the project. The share
of external and internal sources in covering investment costs
under the programme “Enlargement of the Greater Poland
Cancer Centre” in the whole period of 2000–2006 is shown in
Table 7. Table 7 shows, among other things, that total invest-
ment made in 2000–2006 to implement the whole programme
was PLN 70,518,000, including the state budget contribution of
154 reports of practical oncology and radiotherapy 1 7 ( 2 0 1 2 ) 151–156
Table 4 – Number of all employees, all physicians and radiotherapy physicians employed in GPCC in the years 2000–2007.
Year Number of all
employees
All physicians Radiotherapy
physicians
2000 597 90 15
2001 589 86 15
2002 564 87 15
2003 575 77 19
2004 581 81 18
2005 611 85 21
2006 662 94 21
2007 734 101 20
Table 5 – Initial cost of medical equipment compared to radiotherapy accelerators in 2000–2007.
Year Medical equipment in the
hospital
Proportion of accelerators
in all hospital
2000 29,999 45.0%
2001 38,326 32.2%
2002 43,802 31.5%
2003 50,880 52.6%
2004 73,023 45.6%
2005 84,675 46.1%
2006 105,954 37.6%
2007 119,563 43.1%
Table 6 – Depreciation costs for hospital in 2000–2007.
2000 2001 2002 2003 2004 2005 2006 2007
4,553,605 PLN 4,563,695 PLN 5,073,758 PLN 6,447,290 PLN 8295726 PLN 11, 620,358 PLN 13,013,930 PLN 15,809,957 PLN
Table 7 – Overall investment in the enlargement of the Greater Poland Cancer Centre in 2000–2006 (in thousands of PLN).
Years Sources of ﬁnancing Overall
investment
External Own
2000 8172 0 8172
2001 13,311 0 13,311
2002 6944 0 6944
2003 12,301 0 12,301
2004 12,926 89 13,015
2005 12,854 349 13,203
2006 3416 157 3573
ntingTotal 69,923
Source: Own study based on the Greater Poland Cancer Centre’ accou
PLN 69,923,000 and the Greater Poland Cancer Centre’s contri-
bution in the last three years of the programmeof PLN 595,000.
In 2004, the Greater Poland Cancer Centre launched
the other investment programme called “Improvement of
Standards of and Access to Specialist Cancer Treatment
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Fig. 1 – Trends in changing the value of all medical equipment in
thousands of PLN).595 70,518
records.
(Radiotherapy) in the Wielkopolska Region”. That project, as
the name suggests, was targeted exclusively at radiother-
apy. Implemented until 2007, it was ﬁnanced – all the way
through – from two sources only, namely: the European Union
funds and the hospital’s own resources. According to the
4 2005 2006 2007
All hospital equipment
Radiotherapy accelerators
the hospital and value of accelerators in 2000–2007 (in
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Table 8 – Financial results of the hospital in terms of income and costs.
Year Income in thousands of PLN Cost in thousands of PLN Financial result in
thousands of PLN
Hospital Radiotherapy
only
Hospital Radiotherapy only Hospital Radiotherapy
only
2000 43,936 18,159 43,557 11,456 379 6703
2001 49,236 22,039 49,133 11,163 103 10,876
2002 57,002 25,697 56,711 15,294 291 10,403
2003 63,257 30,023 62,935 15,170 322 14,853
2004 69,274 37,379 68,965 17,136 309 20,243
2005 84,224 47,594 83,838 19,472 386 28,122
ﬁ
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a2006 95,783 46,109 95,721
2007 109,347 53,013 120,545
nancing agreement, the EU funds accounted for 75%, while
he hospital’s own contribution for the remaining 25% of the
nvestment. It is worth noting at this point that external con-
ributionwas awarded as a refund of costs previously incurred
y the hospital. Overall costs of that programme amounted
o PLN 56,673,000, including PLN 30,908,000 from the Greater
oland Cancer Centre’s own resources and PLN 25,765,000
rom the European Regional Development Fund. The speci-
cation of key expenses under the programme “Improvement
f Standards of and Access to Specialist Cancer Treatment
Radiotherapy) in the Wielkopolska Region”.
With a ﬁnancial burden so heavy, the hospital Manage-
ent had to apply a careful economic calculation to prevent
he institution from losing its ﬁnancial liquidity in any of the
ears to come and to ensure a return on the investment as
oon as possible. Both investment undertakingswere success-
ul. The hospital maintained its ﬁnancial liquidity over those
ifﬁcult four years. Despite the fact that in 2007, mainly due
o a sudden increase in depreciation costs which reached the
evel of nearly PLN 16 million causing the hospital to record
n exceptional negative balance, the very next year the result
as positive again, owing largely to the increase in the income
rom radiotherapy procedures exceeding PLN 33 million.
Thehospital, like every other economic entity,when choos-
ng the direction of its investments should be guided by
heir effectiveness and strive to maintain positive ﬁnancial
tanding. The negative ﬁnancial result in 2007 was caused to
he greatest extent by the effects of modernization that was
arried out, particularly in the radiotherapy infrastructure,
s shown by the increased value of radiotherapy accelera-
ors (Table 5). However, implementation of new buildings,
quipment and medical appliances results in the increase of
epreciation costs, which was revealed in the authors study,
ystematically from2004 to 2007 by 90% of total increase and it
ad an inﬂuence on the ﬁnal ﬁnancial result of the hospital. In
007, depreciation costs were almost twice as high as in 2004.
he additional factor to consider was the increase of operat-
ng costs connected with extensive use of modern and thus
ore expensive equipment which used more consumables
nd required more labor (Table 8).
Interestingly, the study revealed that a signiﬁcant increase
n the number of patients treated in the study period (which
orresponds to a larger volume of service provided) was
chieved by more extensive use of the same number of ther-
peutic machines (Table 1). However, it is worth noticing21,085 62 25,024
25,050 −11,198 27,963
that beginning with 2003, each year one old accelerator was
replaced with a new one equipped with IMRT and other func-
tionalities (Table 1). From a purely economic point of view,
such approach was not justiﬁed by the expected increase
of radiotherapy service volume which could be reimbursed
(purchased) by the National Health Fund. The new and more
sophisticated accelerators enabled to provide more accurate
treatments, which, however, required more work-intensive
therapy planning and more time dedicated at each machine
for patient irradiation. These were not set off by the epidemi-
ological need and economical incentive of more patients to
be treated.9 Therefore, additional measures had to be under-
taken in order to pay back the money used for radiotherapy
base modernization.
The hospital itself has some properties of a regular mar-
ket entity. In some health care systems, more sophisticated
medical procedures are covered by higher reimbursement, so
that they do not affect strongly the economic performance.
In European countries major providers of health services are
based on public money and usually a public health care unit
plays partly a role of an economic enterprise with special pub-
lic duty for which market economy has limited signiﬁcance.8
These two contradicted aims are differently accomplished in
different EU countries.
Due to the above-mentioned fundamental constraints, it
is difﬁcult to study performance of a hospital with no regard
to the function it performs for the community. According to
the functional theory of social and economic systems, every
change causes general disturbances in the functioning of
a given organization.10 If behind this thesis lies the belief
that such an institution as a hospital is a system composed
of many different elements, among which prevails a rela-
tive equilibrium, then, in consequence, every change of any
of these elements at least periodically destabilizes the whole
system. The more important are the functions in the struc-
ture of the system the element subject to a change fulﬁls, the
more serious are the consequences for thewhole system. This
would explain why the change consisting of modernization of
the radiotherapy base in the studied hospital caused conse-
quences that impacted the economic position of the whole
institution. The main cause of the balance sheet loss in 2007
recorded in the hospital was – as determined earlier – the
occurrence of the so-called rolling costs, being a consequence
of the use of modern treatment appliances and expressed by
the increase in depreciation and operating costs.
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In the study region, the radiotherapy service was insuf-
ﬁcient in order to serve the population.9 Therefore, the
investment in radiotherapy equipment was justiﬁed from
the epidemiological point of view. This brought two conse-
quences: improved quality of the service, measured by the
increased proportion of more sophisticated conformal radio-
therapy, and, directly, by a very signiﬁcant increase in the
number of radiotherapy patients. The increase in the num-
ber of patients with a constant number of accelerators can
be explained by a better performance of new equipment and
higher “up” time but is also linked with the more challeng-
ing possibilities whichmodern equipment offers to staff. Such
investments, while not bringing immediate ﬁnancial proﬁts,
were rational and necessary in the long-term perspective.
On the other hand, the suspension of expenditures on mod-
ernization of radiotherapy would lead to hospital’s losing its
credibility in the increasingly competitive and Europe wide
market of medical services.11–13
In all medical disciplines, investment normally has to be
associated with better clinical results, larger volumes of ser-
vice provided or better quality of service. In oncology, it is not
easy to evaluate the inﬂuence of the cost increase and related
improvement of clinical results, because they can only be seen
after many years; usually more than ﬁve. The quality of ser-
vice is associated with the quality of management systems
(like ISO) and clinical audits.14–17 The implementation of ISO
and clinical audits requires additional workload and the more
sophisticated equipment is in use, the more extensive – thus
costly – quality assurance procedures are required.18,19
The modernization strategy of health care units includes
not only innovation driven by the idea of securing better eco-
nomical status of a hospital but also to ensure proper quality
level of medical services provided.20 Moreover, hospitals in
which – as in the GPCC – radiotherapy is used also have to
fulﬁl speciﬁc conditions associated with a safe use of ioniz-
ing radiation. To meet these requirements, hospitals have to
allocate certain costs to maintain radiological safety.
6. Conclusion
Investments modernizing the radiotherapy infrastructure led
to a signiﬁcant increase in depreciation and operating costs of
the hospital, which temporarily worsened its ﬁnancial results.
More sophisticated radiotherapy enabled to provide more
accurate treatments, which while requiring more time to be
dedicated for each patient, triggered more effective use of
resources and allowed for more patients to be treated.
Long term trends showed that investments had positive
inﬂuence on hospital performance which was manifested on
the ﬁnancial level by increased income and on the community
level by increased number of patients treated.Conﬂict interest
None declared.
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